Genesystem Statistics

Total Valuation

Genesystem has a market cap or net worth of KRW 29.50 billion. The enterprise value is 32.21 billion.

Market Cap	29.50B
Enterprise Value	32.21B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Genesystem has 6.82 million shares outstanding. The number of shares has decreased by -1.17% in one year.

Current Share Class	6.82M
Shares Outstanding	6.82M
Shares Change (YoY)	-1.17%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	19.40%
Owned by Institutions (%)	15.98%
Float	5.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	85.41
PB Ratio	1.90
P/TBV Ratio	4.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.60
EV / Sales	93.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.23

Financial Position

The company has a current ratio of 2.24, with a Debt / Equity ratio of 0.26.

Current Ratio	2.24
Quick Ratio	1.44
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-0.53
Interest Coverage	-78.51

Financial Efficiency

Return on equity (ROE) is -49.96% and return on invested capital (ROIC) is -26.53%.

Return on Equity (ROE)	-49.96%
Return on Assets (ROA)	-22.91%
Return on Invested Capital (ROIC)	-26.53%
Return on Capital Employed (ROCE)	-47.17%
Revenue Per Employee	6.40M
Profits Per Employee	-165.61M
Employee Count	54
Asset Turnover	0.01
Inventory Turnover	1.10

Taxes

Income Tax	-153.36M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -55.13% in the last 52 weeks. The beta is 0.51, so Genesystem's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-55.13%
50-Day Moving Average	5,761.50
200-Day Moving Average	7,621.90
Relative Strength Index (RSI)	25.87
Average Volume (20 Days)	80,929

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genesystem had revenue of KRW 345.38 million and -8.94 billion in losses. Loss per share was -1,313.13.

Revenue	345.38M
Gross Profit	-2.23B
Operating Income	-9.94B
Pretax Income	-9.73B
Net Income	-8.94B
EBITDA	-8.71B
EBIT	-9.94B
Loss Per Share	-1,313.13

Full Income Statement

Balance Sheet

The company has 3.48 billion in cash and 4.07 billion in debt, giving a net cash position of -587.96 million or -86.20 per share.

Cash & Cash Equivalents	3.48B
Total Debt	4.07B
Net Cash	-587.96M
Net Cash Per Share	-86.20
Equity (Book Value)	15.51B
Book Value Per Share	1,963.01
Working Capital	3.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.26 billion and capital expenditures -345.08 million, giving a free cash flow of -7.61 billion.

Operating Cash Flow	-7.26B
Capital Expenditures	-345.08M
Free Cash Flow	-7.61B
FCF Per Share	-1,115.44

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,876.83%
Pretax Margin	-2,817.15%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genesystem does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.17%
Shareholder Yield	1.17%
Earnings Yield	-30.32%
FCF Yield	-25.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Genesystem has an Altman Z-Score of 3.18 and a Piotroski F-Score of 2.

Altman Z-Score	3.18
Piotroski F-Score	2